TNON Company Profile and Key Details

Tenon Medical, Inc. (NASDAQ:TNON) closed at $2.44 USD, losing -$0.92 (-27.38%) from the previous close of $3.36. The stock is currently within 5% of its 52-week low $2.40 and $50.40. With a market capitalization of about $1.21 million, Tenon Medical, Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~1.36). Key stats such as the average daily volume over the past year has been around 1.58 million shares, trading with heavier-than-usual volume. Headquartered in Los Gatos, CA, Tenon Medical, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Steven Foster, the company employs approximately 26 people and listed since April 27, 2022. Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States.

TNON has shown mixed momentum, gaining 1.88% over the past week and -21.69% over the past quarter, though year-to-date performance is up 2.05%. Short-term trend indicators are bullishly aligned (SMA20 8.17%, SMA50 -6.62%, SMA200 -21.89%). The stock’s 14-day RSI is 51.56 (neutral), while the ATR of 0.07 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -85.35% below its high and over 33.68% above its low. Average 10-day trading volume of 1.77 million shares is slightly above the 3-month average of 1.37 million, indicating heightened recent market interest.

Tenon Medical, Inc. trades at a P/E ratio of -0.07, slightly below the S&P 500 average, with a price-to-sales ratio of 0.31 and a price-to-book ratio of -0.62 indicating negative book value, which may reflect financial stress. The P/FCF stands at -0.14, also above market averages.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Tenon Medical, Inc. generated EPS of -$2.76 over the past year. Five-year average earnings growth is -25.43%. Wall Street analysts project EPS growth of 59.74% annually over the next five years. The latest quarter delivered EPS of -$12.35. The next quarter is forecast at -$0.36. Next year's EPS is expected at $62.98. Tenon Medical, Inc. earnings surprise history is a mixed track record. The quarter that ended August 13, 2026, missed forecasts by 47.02%. The prior quarter beat by 1.64%. Over the last six quarters, Apple has recorded several small beats. These include -9.01% in May 13, 2025.

Tenon Medical, Inc. has 667.05 thousand shares outstanding. The public float is 620.85 thousand shares, elevated short interest at 1.40% of float. This equals 6.38 thousand shares. The short ratio is 0.05 days. Institutional investors hold 7.49% of the float. Insiders own 9.06%. Grawey Nathaniel A. holds 101.17 thousand shares, VAN DICK STEVEN M has 100.42 thousand shares and GINN RICHARD has 85.32 thousand shares. Over the past six months, insider transactions show net selling. They sold 5.74 thousand shares across 5 transactions.